In addition to non-contrasted Computed Tomography (CT) scans showing low-density masses, some of which have a cystic component, the diagnosis is based on laboratory findings showing negative serum alpha-fetoprotein levels and negative results for other traditional tumor markers (carcinoembryonic antigen, CA125, and CA19–9). This evidence concerns the gene AFP and neoplasm.